These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 18392502)

  • 21. Clinical analysis and nonsurgical management of 11 dogs with aural cholesteatoma.
    Imai A; Kondo H; Suganuma T; Nagata M
    Vet Dermatol; 2019 Feb; 30(1):42-e12. PubMed ID: 30637895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunohistochemical study on proliferative activity of experimental cholesteatoma.
    Park K; Park HJ; Chun YM
    Eur Arch Otorhinolaryngol; 2001 Mar; 258(3):101-5. PubMed ID: 11374247
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cholesteatoma induction. Consequences of external auditory canal ligation in gerbils, cats, hamsters, guinea pigs, mice and rats.
    McGinn MD; Chole RA; Henry KR
    Acta Otolaryngol; 1984; 97(3-4):297-304. PubMed ID: 6720306
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cholesteatoma prevention by local treatment with vitamin A.
    Nageris BI; Grushko I; Feinmesser R
    Otol Neurotol; 2001 Sep; 22(5):576-8. PubMed ID: 11568660
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Effect of Oral Montelukast Administration in Cholesteatoma Development and Inflammation: An Experimental Animal Model.
    Ocal R; Kargin Kaytez S; Yumusak N; Akkoca O; Celik H; Arslan N
    Otol Neurotol; 2021 Jun; 42(5):e568-e572. PubMed ID: 33481545
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acquired ear canal cholesteatoma in congenital aural atresia/stenosis.
    Casale G; Nicholas BD; Kesser BW
    Otol Neurotol; 2014 Sep; 35(8):1474-9. PubMed ID: 25080039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Silent intratympanic membrane cholesteatoma.
    Jaisinghani VJ; Paparella MM; Schachern PA
    Laryngoscope; 1998 Aug; 108(8 Pt 1):1185-9. PubMed ID: 9707241
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Classification of Cholesteatoma According to Growth Patterns.
    Rosito LS; Netto LF; Teixeira AR; da Costa SS
    JAMA Otolaryngol Head Neck Surg; 2016 Feb; 142(2):168-72. PubMed ID: 26747599
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Epithelium-stroma interaction in cholesteatoma of the middle ear].
    Jacob R; Welkoborsky HJ; Mann W
    Laryngorhinootologie; 2001 Jan; 80(1):11-7. PubMed ID: 11272241
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of 5-fluorouracil in cholesteatoma development in an animal model.
    Wright CG; Bird LL; Meyerhoff WL
    Am J Otolaryngol; 1991; 12(3):133-8. PubMed ID: 1928597
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased proliferation and migration of epithelium in advancing experimental cholesteatomas.
    Kim HJ; Tinling SP; Chole RA
    Otol Neurotol; 2002 Nov; 23(6):840-4. PubMed ID: 12438843
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Using surgical observations of ossicular erosion patterns to characterize cholesteatoma growth.
    Maresh A; Martins OF; Victor JD; Selesnick SH
    Otol Neurotol; 2011 Oct; 32(8):1239-42. PubMed ID: 21921854
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of mastoid cavity obliteration on the growth of experimentally produced residual cholesteatoma.
    Hinohira Y; Gyo K; Yanagihara N; Bredberg G; Alsterborg E
    Acta Otolaryngol; 1998 Jan; 118(1):101-4. PubMed ID: 9504172
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Experimental induction of middle ear cholesteatoma in rats.
    Huang CC; Shi GS; Yi ZX
    Am J Otolaryngol; 1988; 9(4):165-72. PubMed ID: 3265859
    [TBL] [Abstract][Full Text] [Related]  

  • 35. KGFR as a possible therapeutic target in middle ear cholesteatoma.
    Yamamoto-Fukuda T; Akiyama N; Shibata Y; Takahashi H; Ikeda T; Kohno M; Koji T
    Acta Otolaryngol; 2014 Nov; 134(11):1121-7. PubMed ID: 25315911
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Congenital cholesteatoma clinical features and surgical results.
    Kojima H; Tanaka Y; Shiwa M; Sakurai Y; Moriyama H
    Am J Otolaryngol; 2006; 27(5):299-305. PubMed ID: 16935171
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Animal models of middle ear cholesteatoma.
    Yamamoto-Fukuda T; Takahashi H; Koji T
    J Biomed Biotechnol; 2011; 2011():394241. PubMed ID: 21541229
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of histopathological aspects in acquired middle ear cholesteatoma.
    Alves AL; Pereira CSB; Ribeiro FAQ; Fregnani JHTG
    Braz J Otorhinolaryngol; 2008; 74(6):835-841. PubMed ID: 19582339
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathogenesis of middle ear cholesteatoma: a new model of experimentally induced cholesteatoma in Mongolian gerbils.
    Yamamoto-Fukuda T; Hishikawa Y; Shibata Y; Kobayashi T; Takahashi H; Koji T
    Am J Pathol; 2010 Jun; 176(6):2602-6. PubMed ID: 20413684
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autologous meatal skin graft implantation and intratympanic injection of Pseudomonas aeruginosa: a new experimental mouse model of acquired middle ear cholesteatoma.
    Si Y; Chen YB; Chen QX; Liu Y; Jiang HL; Zhang ZG; Huang X
    ORL J Otorhinolaryngol Relat Spec; 2013; 75(5):274-81. PubMed ID: 24030443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.